QSOX1 and colitis: Importantly, we show here that administration of QSOX1 inhibitory antibodies did not potentiate DSS‐induced colitis (Fig 1B), demonstrating that QSOX1 activity in colon physiology, and probably the Golgi functions of QSOX1 in general, are protected from inhibition by systemic inhibitory antibody treatment.